Production, regulation and role of nitric oxide in glial cells

Mediators of Inflammation

Volumn 7, Issue 4, 1998, Pages 239-255

  Vincent, V A M ^a   Tilders, F J H ^a   Van Dam, A M ^a  

^a VU UNIVERSITY AMSTERDAM   (Netherlands)

Author keywords

Astroglia; Microglia; Neurodegeneration; Nitric oxide synthase; Plasminogen activators; Transforming growth factor

Indexed keywords

CYTOKINE; INTERLEUKIN 1; INTERLEUKIN 5; NERVE GROWTH FACTOR; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PLASMINOGEN ACTIVATOR; TRANSFORMING GROWTH FACTOR BETA;

ALZHEIMER DISEASE; CELL ACTIVATION; CELL INTERACTION; CELL SURVIVAL; DEMENTIA; GLIA CELL; IMMUNOREGULATION; MACROGLIA; MICROGLIA; MULTIPLE SCLEROSIS; NERVE CELL DEGENERATION; NERVE CELL LESION; NERVE FIBER GROWTH; NEUROPROTECTION; NEUROTOXICITY; PARKINSON DISEASE; PRIORITY JOURNAL; REVIEW;

ANIMALS; CELL COMMUNICATION; HUMANS; NEUROGLIA; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; TRANSFORMING GROWTH FACTOR BETA;

EID: 0031656992     PISSN: 09629351     EISSN: None     Source Type: Journal    
DOI: 10.1080/09629359890929     Document Type: Review

References (372)

1. Virchow R. Ueber das Granulierte ansehen der Wandungen der Gehirnventrikel. Allg Z Psychiatrie 1846; 3: 242-250.
2. Somjen GG. Nervenkitt: notes on the history of the concept of neuroglia. GLIA 1988; 1: 2-9.
3. Itagaki S, McGeer PL, Akiyama H, Zhu S, Selkoe D. Relationship of microglia and astrocytes to amyloid deposits of Alzheimer's disease. J Neuroimmunol 1989; 24: 173-182.
4. McGeer PL, Akiyama H, Itagaki S, McGeer EG. Immune system response in Alzheimer's disease. Can J Neurol Sci 1989; 16: 519-527.
5. McGeer PL, Itagaki S, Boyes BE, McGeer EG. Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson's and Alzheimer's disease brains. Neurology 1988; 38: 1285-1291.
6. McGeer PL, Itagaki S, Tago H, McGeer EG. Reactive microglia in patients with senile dementia of the Alzheimer type are positive for the histocompatibility glycoprotein HLA-DR. Neurosci Lett 1987; 79: 195-200.
7. Rozemuller JM, Eikelenboom P, Pals ST, Stam FC. Microglial cells around amyloid plaques in Alzheimer's disease express leucocyte adhesion molecules of the LFA-1 family. Neurosci Lett 1989; 101: 288-292.
8. Woodroofe MN, Bellamy AS, Feldman M, Davison AN, Cuzner ML. Immunocytochemical characterization of the immune reaction in the central nervous system in multiple sclerosis. Possible role for microglia in lesion growth. J Neurol Sci 1986; 74: 135-152.
9. Koka P, He K, Zack JA, Kitchen S, Peacock W, Fried I, et al. Human immunodeficiency virus 1 envelope proteins induce interleukin 1, tumor necrosis factor alpha, and nitric oxide in glial cultures derived from fetal, neonatal, and adult human brain. J Exp Med 1995; 182: 941-952.
10. Dickson DW, Lee SC, Hatch W, et al. Macrophages and microglia in HIV-related CNS neuropathology. In: Price RW, Perry SW, eds. HIV, AIDS and the Brain. New York: Raven Press, 1994; 99-118.
11. Giulian D, Yu J, Li X, Tom D, Li J, Wendt E, et al. Study of receptor-mediated neurotoxins released by HIV-1-infected mononuclear phagocytes found in human brain. J Neurosci 1996; 16: 3139-3153.
12. Rio-Hortega P, Microglia. In: Penfield W, ed. Cytology and Cellular Pathology of the Nervous System, Vol. 2. New York: Hoeber, 1932; 481-534.
13. Lawson LJ, Perry VH, Dri P, Gordon S. Heterogeneity in the distribution and morphology of microglia in the normal, adult mouse brain. Neuroscience 1991; 39: 151-170.
14. Murabe Y, Sano Y. Morphological studies on neuroglia. Cell Tissue Res 1982; 225: 469-485.
15. Ling E, Wong W. The origin and nature of ramified and amoeboid microglia: a historical review and current concepts. GLIA 1993; 7: 9-18.
16. Boya J, Calvo JL, Carbonell AL, Borregon A. A lectin histochemistry study on the development of rat microglial cells. J Anat 1991; 175: 229-236.
17. Murabe Y, Sano Y. Morphological studies on neuroglia. VII. Distribution of 'brain macrophages' in brains of neonatal and adult rats, as determined by means of immunohistochemistry. Cell Tissue Res 1983; 229: 85-95.
18. Perry VH, Hume DA, Gordon S. Immunohistochemical localization of macrophages and microglia in the adult and developing mouse brain. Neuroscience 1985; 15: 313-326.
19. Marty S, Dusart I, Peschanski M. Glial changes following an excitotoxic lesion in the CNS-Microglia macrophages. Neuroscience 1991; 45: 529-539.
20. Leong S, Ling E. Amoeboid and ramified microglia: their interrelationship and response to brain injury. GLIA 1992; 6: 39-47.
21. Killackey HP. Glia and the elimination of transient cortical projections. Trends Neurosci 1984; 7: 225-226.
22. Giulian D, Chen J, Ingeman JE, George JK, Naponen M. The role of mononuclear phagocytes in wound healing after traumatic injury to adult mammalian brain. J Neurosci 1989; 9: 4416-4429.
23. Stoll G, Trapp BD, Griffin JW. Macrophage function during Wallerian degeneration of rat brain optic nerve: clearance of degenerating myelin and Ia expression. J Neurosci 1989; 9: 2327-2335.
24. Murabe Y, Ibata Y, Sano Y. Morphological studies on neuroglia. III. Macrophage response and 'microgliocytosis' in kainic acid-induced lesions. Cell Tissue Res 1981; 218: 75-85.
25. Fujita S, Tsuchihashi Y, Kitamura T. Origin, morphology and function of the microglia. Prog Clin Biol Res 1981; 59A: 141-169.
26. Imamoto K. Origin of microglia: cell transformation from blood monocytes into macrophagic ameboid cells and microglia. Prog Clin Biol Res 1981; 59A: 125-139.
27. Hickey WF, Kimura H. Perivascular microglial cells of the CNS are bone marrow-derived and present antigen in vivo. Science 1988; 239: 290-292.
28. Hickey WF, Vass K, Lassmann H. Bone marrow-derived elements in the central nervous system: an immunohistochemical and ultrastructural survey of rat chimeras. J Neuropathol Exp Neurol 1992; 51: 246-256.
29. De Groot CJA, Huppes W, Sminia T, Kraal G, Dijkstra CD. Determination of the origin and nature of brain macrophages and microglial cells in mouse central nervous using non-radioactive in situ hybridization and immunoperoxidase techniques. GLIA 1992; 6: 301-309.
30. Matsumoto Y, Fujiwara M. Absence of donor-type major histocompatibility complex class 1 antigen bearing microglia in the rat central nervous system of radiation bone marrow chimeras. J Neuroimmunol 1987; 17: 71-82.
31. Ting JP, Nixon DF, Weiner LP, Frelinger JA. Brain Ia antigens have a bone marrow origin. Immunogenetics 1983; 17: 295-301.
32. Schultze B, Korr H. Cell kinetic studies of different cell types in the developing and adult brain of the rat and the mouse: a review. Cell Tissue Kinet 1981; 14: 309-325.
33. Graeber MB, Tetzlaff W, Streit WJ, Kreutzberg GW. Microglial cells but not astrocytes undergo mitosis following rat facial nerve axotomy. Neurosci Lett 1988; 85: 317-321.
34. Alliot F, Lecain E, Grima B, Pessac B. Microglial progenitors with a high proliferative potential in the embryonic and adult mouse brain. Proc Natl Acad Sci USA 1991; 88: 1541-1545.
35. Lawson LJ, Perry VH, Gordon S. Turnover of resident microglia in the normal adult mouse brain. Neuroscience 1992; 48: 405-415.
36. Streit WJ, Graeber MB, Kreutzberg GW. Functional plasticity of microglia: a review. GLIA 1988; 1: 301-307.
37. Lassmann H, Schmied M, Vass K, Hickey WF. Bone marrow derived elements and resident microglia in brain inflammation. GLIA 1993; 7: 19-24.
38. Kibayashi K, Mastri AR, Hirsch CS. Neuropathology of human immunodeficiency virus infection at different disease stages. Hum Pathol 1996; 27: 637-642i.
39. Budka H, Costianzi G, Cristina A, Lechi A, Parravicini C, Trabattoni R, et al. Brain pathology induced by infection with the human immunodeficiency virus (HIV). A histological, immunocytochemical, and electron microscopical study of 100 autopsy cases. Acta Neuropathol 1987; 75: 185-198.
40. Calvo C, Yoshimura T, Gelman M, Mallat M. Production of monocyte chemotactic protein-1 by rat brain macrophages. Eur J Neurosci 1996; 8: 1725-1734.
41. Frei K, Siepl C, Groscurth P, Bodmer S, Fontana A. Immunobiology of microglial cells. Ann NY Acad Sci 1987; 540: 218-227.
42. Perry VH, Gordon S. Macrophages and microglia in the nervous system. TINS 1988; 11: 273-277.
43. Perry VH, Gordon S. Modulation of CD4 antigen on macrophages and microglia in rat brain. J Exp Med 1987; 166: 1138-1143.
44. Bo L, Mork S, Kong PA, Nyland H, Pardo CA, Trapp BD. Detection of MHC class II-antigens on macrophases and microglia, but not on astrocytes and endothelia in active multiple sclerosis lesions. J Neuroimmunol 1994; 51: 135-146.
45. Tooyama I, Kimura H, Akiyama H, McGeer PL. Reactive microglia express class I and class II major histocompatibility complex antigens in Alzheimer's disease. Brain Res 1990; 523: 273-280.
46. McRae A, Gilland E, Bona E, Hagberg H. Microglia activation after neonatal hypoxic-ischaemia. Dev Brain Res 1995; 84: 245-252.
47. Suzumura A, Sawada M, Marunouchi R, Yamamoto H. Proliferation of microglia with IL-4. Neuroimmunol 1993; 1: 248-263.
48. Oehminchen M. Inflammatory cells in the central nervous system: an integrating concept based on recent research in pathology, immunology, and forensic medicine. In: Progress in Neuropathology. New York: Raven Press, 1983; 277-296.
49. Yao J, Harvath L, Gilbert DL, Colton CA. Chemotaxis by a CNS macrophage, the microglia. J Neurosci 1990; 27: 36-42.
50. Giulian D, Baker TJ, Shih LN, Lachman LB. Interleukin 1 of the central nervous system is produced by ameboid microglia. J Exp Med 1986; 164: 594-604.
51. Vincent VAM, Van Dam A-M, Persoons JHA, Schotanus K, Steinbusch HWM, Schoffelmeer ANM, et al. Gradual inhibition of inducible nitric oxide synthase but not of interleukin-1β production in rat microglial cells of endotoxin-treated mixed glial cell cultures. GLIA 1996; 17: 94-102.
52. Yao J, Keri JE, Taffs RE, Colton CA. Characterization of interleukin-1 production by microglia in culture. Brain Res 1992; 591: 88-93.
53. Hetier E, Ayala J, Denefle P, Bousseau A, Rouget P, Mallat M, et al. Brain macrophages synthesize interleukin-1 and interleukin-1 mRNAs in vitro. J Neurosci Res 1988; 21: 398-397.
54. Hetier E, Ayala J, Bousseau A, Prochiantz A. Modulation of interleukin-1 and tumor necrosis factor expression by β-adrenergic agonists in mouse ameboid microglial cells. Exp Brain Res 1991; 86: 407-413.
55. Griffin WS, Stanley LC, Ling C, White L, MacLeod V, Perrot LJ, et al. Brain interleukin 1 and S-100 immunoreactivity are elevated in down syndrome and Alzheimer's disease. Proc Natl Acad Sci USA 1989; 86: 7611-7615.
56. Sawada M, Kondo N, Suzumura A, Marunouchi T. Production of tumour necrosis factor-alpha by microglia and astrocytes in culture. Brain Res 1989; 491: 394-397.
57. Chao CC, Hu S, Close K, Choi CS, Molitor TW, Novick WJ, et al. Cytokine release from microglia: differential inhibition by pentoxifylline and dexametasone. J Infect Dis 1992; 166: 847-853.
58. Sebire G, Emilie D, Wallon C, Hery C, Devergne O, Delfraissy J, et al. In vitro production of IL-6, IL-1β, and tumor necrosis factor-alpha by human embryonic microglial and neural cells. J Immunol 1993; 150: 1517-1523.
59. Lee SC, Liu W, Dickson DW, Brosnan CF, Berman JW. Cytokine production by human fetal microglia and astrocytes. J Immunol 1993; 150: 2659-2667.
60. Constam DB, Philipp J, Malipiero UV, ten Rijke P. Differential expression of transforming growth factor-β1, -β2, and -β3 by glioblastoma cells. astrocytes, and microglia. J Immunol 1992; 148: 1404-1410.
61. Kiefer R, Gold R, Gehrmann J, Lindholm D, Wekerle H, Kreutzberg GW. Transforming growth factor beta expression in reactive spinal cord microglia and meningeal inflammatory cells during experimental allergic neuritis. J Neurosci Res 1993; 36: 391-398.
62. Vincent VAM, Tilders FJH, Van Dam A-M. Inhibition of endotoxin-induced nitric oxide synthase production in microglial cells by the presence of astroglial cells: a rule for transforming growth factor β. GLIA 1997; 19: 190-198.
63. Minghetti L, Polazzi E, Nicolini A, Creminon C, Levi G. Interferon-gamma and nitric oxide down-regulate lipopolysaccharide-induced prostanoid production in cultured rat microglial cells by inhibiting cyclooxygenase-2 expression. J Neurochem 1996; 66: 1963-1970.
64. Giulian D, Corpuz M, Richmond B, Wendt E, Hall ER. Activated microglia are the principal source of thromboxane in the central nervous system. Neurochem Int 1996; 29: 65-76.
65. Matsuo M, Hamasaki Y, Fujiyama F, Miyazaki S. Eicosanoids are produced by microglia, not by astrocytes, in rat glial cell cultures. Brain Res 1995; 685: 201-204.
66. Sawada M, Suzumura A, Itoh Y, Marunouchi T. Production of interleukin-5 by mouse astrocytes and microglia in culture. Neurosci Lett 1993; 155: 175-178.
67. Williams K, Dooley N, Ulvestad E, Becher B, Antel JP. IL-10 production by adult human derived microglial cells. Neurochem Int 1996; 29: 55-64.
68. Mizuno T, Sawada M, Marunouchi T, Suzumura A. Production of interleukin-10 by mouse glial cells in culture. Biochem Biophys Res Commun 1994; 205: 1907-1915.
69. Cunha FQ, Moncada S, Liew FY. Interleukin-10 (IL-10) inhibits the induction of nitric oxide synthase by interferon-gamma in murine macrophages. Biochem Biophys Res Comm 1992; 182: 1155-1159.
70. Oswald IP, Gazzinelli RT, Sher A, James SL. IL-10 synergizes with IL-1 and transforming growth factor-β to inhibit macrophage cytotoxic activity. J Immunol 1992; 148: 3578-3582.
71. Hu S, Sheng WS, Peterson PK, Chao CC. Cytokine modulation of murine microglial cell superoxide production. GLIA 1995; 13: 45-50.
72. Raff MC, Abney ER, Miller RH. Two glial cell lineages diverge prenatally in the rat optic nerve. Dev Biol 1984; 106: 53-64.
73. Cameron RS, Rakic P. Glial cell lineage in the cerebral cortex: a review and synthesis. GLIA 1991; 4: 124-137.
74. Misson J, Takahashi T, Caviness VS Jr. Ontogeny of radial and other astroglial cells in murine cerebral cortex. GLIA 1991; 4: 138-148.
75. Goldman JE, Vaysse PJ. Tracing glial cell lineages in the mammalian forebrain. GLIA 1991; 4: 149-156.
76. Noble M. Points of controversy in the 0-2A lineage clocks and type-2 astrocytes. GLIA 1991; 4: 157-164.
77. Martin PM, O'Callaghan JP. A direct comparison of GFAP immunocytochemistry and GFAP concentration in various regions of ethanol-fixed rat and mouse brain. J Neurosci Meth 1995; 58: 181-192.
78. Eng LF, DeArmond SJ. Immunocytochemical studies of astrocytes in normal development and disease. Adv Cell Neurobiol 1982; 3: 145-171.
79. Akimoto J, Itoh H, Miwa T, Ikeda K. Immunohistochemical study of glutamine synthetase expression in early glial development. Dev Brain Res 1993; 72: 9-14.
80. Caldini M, Rolland B, Fages C, Tardy M. Glutamine synthetase activity during mouse brain development. Experientia 1982; 38: 1199-1202.
81. Shehab SAS, Cronly-Dillon JR, Nona SN, Stafford CA. Preferential histochemical staining of protoplasmic and fibrous astrocytes in rat CNS with GFAP antibodies using different fixatives. Brain Res 1990; 518: 347-352.
82. Miller RH, Raff MC. Fibrous and protoplasmic astrocytes are biochemically and developmentally distinct. J Neurocytol 1984; 15: 187-192.
83. Ogawa M, Araki M, Nagatsu I, Yoshida M. Astroglial cell alteration caused by neurotoxins: immunohistochemical observations with antibodies to glial fibrillary acidic protein, laminin, and tyrosine hydroxylase. Exp Neur 1989; 106: 187-196.
84. Dell'Anna ME, Geloso MC, Draisci G, Luthman J. Transient changes in Fos and GFAP immunoreactivity precede neuronal loss in the rat hippocampus following neonatal anoxia. Exp Neur 1995; 131: 144-156.
85. O'Callaghan JP. Assessment of neurotoxicity: use of glial fibrillary acidic protein as a biomarker. Biomed Environ Sci 1991; 4: 197-206.
86. O'Callaghan JP, Jensen KF. Enhanced expression of glial fibrillary acidic protein and the cupric silver degeneration reaction can be used as sensitive and early indicators of neurotoxicity. Neuro Tox 1992; 13: 113-122.
87. Levi-Montalcini R. Angletti PU. Nerve growth factor. Physiol Rev 1968; 48: 534-569.
88. Gonzalez D, Les Dees W, Kiney JK, Ojeda SR, Saneto RP. Expression of β-nerve growth factor in cultured cells derived from the hypothalamus and cerebral cortex. Brain Res 1990; 511: 249-258.
89. Friedman WJ, Larkfors J, Ayer-le-Lievre C, Ebendal T, Olson L, Persson H. Regulation of beta nerve growth factor expression by inflammatory mediators in hippocampal cultures. J Neurosci Res 1990; 27: 374-382.
90. Lindholm D, Heumann R, Meyer M, Thoenen H. Interleukin-1 regulates synthesis of nerve growth factor in non-neuronal cells of rat sciatic nerve. Nature 1987; 330: 658-659.
91. Bandtlow CE, Meyer M, Lindholm D, Sprangler M, Heuman R, Thoenen H. Regional and cellular codistribution of interleukin-1 beta and nerve growth factor mRNA in the adult rat brain: possible relationship to the regulation of nerve growth factor synthesis. J Cell biol 1990; 111: 1701-1711.
92. Spranger M, Lindholm D, Bandtlow C, Heumann R, Gnahn H. Naher-Noe M, et al. Regulation of nerve growth factor (NGF) synthesis in the rat central nervous system: comparison between the effects of interleukin-1 and various growth factors in astrocyte cultures in vivo. Eur J Neurosci 1990; 2: 69-76.
93. Gadient RA, Cron KC, Otten U. Interleukin-1β and tumor necrosis factor-alpha synergistically stimulate nerve growth factor (NGF) release from cultured rat astrocytes. Neurosci Lett 1990; 117: 335-340.
94. Awatsuji H, Furukawa Y, Hirota M, Murakami Y, Nii S, Furakawa S, et al. Interleukin-4 and -5 as modulators of nerve growth factor synthesis/ secretion in astrocytes. J Neurosci Res 1993; 34: 539-545.
95. Rudge JS, Pasnikowski EM, Hoslst P, Lindsay RM. Changes in neurotrophic factor expression and receptor activation following exposure of hippocampal neuron/astrocyte cocultures to kainic acid. J Neurosci 1995; 15: 6856-6867.
96. Mocchetti I, Wrathall JR. Neurotrophic factors in central nervous system trauma. J Neurotrauma 1995; 12: 853-870.
97. Fontana A, Kristensen F, Dubs R, Gemsa D, Weber E. Production of prostaglandin E and an interleukin-1 like factor by cultured astrocytes and C6 glioma cells. J Immunol 1982; 129: 2413-2419.
98. Nieto-Sampedro M, Berman MA. Interleukin-1-like activity in rat brain: sources, targets, and effect of injury. J Neurosci Res 1987; 17: 214-219.
99. Fontana A, Grob PJ. Astrocyte-derived interleukin-1-like factors. Lymph Res 1984; 3: 11-16.
100. Fontana A, McAdam KPWJ, Kristensen F, Weber E. Biological and biochemical characterization or an interleukin 1-like factor from rat C6 glioma cells. Eur J Immunol 1983; 13: 685-689.
101. Sawada M, Suzumura A, Marunouchi T. TNF-alpha induces IL-6 production by astrocytes but not by microglia. Brain Res 1992; 583: 296-299.
102. Frei K, Bodmer S, Schwerdel C, Fontana A. Astrocytes of the brain synthesize Interleukin 3-like factors. J Immunol 1985; 135: 4044-4047.
103. da Cunha A, Jackson RW, Vitkovic L. HIV-1 non-specifically stimulates production of transforming growth factor-β1 transfer in primarv, astrocytes. J Neuroimmunol 1995; 60: 125-133.
104. da Cunha A, Vitkovic L. Transforming growth factor-beta 1 (TGFβ1) expression and regulation in rat cortical astrocytes. J Neuroimmunol 1992; 36: 157-169.
105. Morganti-Kossmann MC, Kossmann T, Brandes ME, Mergenhagen SE, Wahl SM. Autocrine and paracrine regulation of astrocyte function by transforming growth factor-β. J Neuroimmunol 1992; 39: 163-174.
106. Lee SC, Dickson DW, Brosnan CF. Interleukin-1, nitric oxide and reactive astrocytes. Brain Behav Immun 1995; 9: 345-354.
107. Moline-Holgado F, Lledo A, Guaza C. Evidence for cyclooxygenase activation by nitric oxide in astrocytes. GLIA 1995; 15: 167-172.
108. Brenner T, Yamin A, Abramsky O, Gallily R. Stimulation of tumor necrosis factor-alpha production by mycoplasmas and inhibition by dexametasone in cultured astrocytes. Brain Res 1993; 608: 273-279.
109. Giulian D, Vaca K, Johnson B. Secreted peptides as regulators of neuronglia and glia-glia interactions in the developing nervous system. J Neurosci Res 1988; 21: 487-500.
110. Lee SC, Brosnan CF, Dickson DW. GM-CSF promotes proliferation of human fetal and adult microglia in primary cultures. GLIA 1994; 12: 309-318.
111. Giulian D, Johnson B, Krebs JF, George JK, Tapscott M. Microglial mitogens are produced in the developing and injured mammalian brain. J Cell Biol 1991; 112: 323-333.
112. Lafortune L, Nalbantoglu J, Antel JP. Expression of tumor necosis factor alpha (TNF alpha) and interleukin 6 (IL-6) mRNA in adult human astrocytes: comparison with adult microglia and fetal astrocytes. J Neuropathol Exp Neurol 1996; 55: 515-521.
113. Aloisi F, Borsellino G, Samoggia P, Testa U, Chelucci C, Russo G, et al. Astrocyte cultures from human embryonic brain: characterization and modulation of surface molecules by inflammatory cytokines. J Neurosci Res 1992; 32: 494-506.
114. Fontana A, Fierz W, Wekerle H. Astrocytes present myelin basic protein to encephalitogenic T-cell lines. Nature 1984; 307: 273-276.
115. Lassmann H, Vass K, Brunner C, Seitelberger F. Characterization of inflammatory infiltrates in experimental allergic encephalomyelitis. Progr Neuropathol 1986; 6: 33.
116. Giulian D, Woodward J, Young DG, Krebs JF, Lachman LB. Interleukin-1 injected into mammalian brain stimulates astrogliosis and neovascularization. J Neurosci 1988; 8: 2485-2490.
117. Giulian D, Young DG, Woodward J, Brown DC, Lachman LB. Interleukin-1 is an astroglial growth factor in the developing brain. J Neurosci 1988; 8: 709-714.
118. Giulian D, Tapscott MJ. Immunoregulation of cells within the central nervous system. Brain, Behavior and Immunity 1988; 2: 352-358.
119. Giulian D, Baker TJ. Peptides released by ameboid microglia regulate astroglial proliferation. J Cell Biol 1985; 101: 2411-2415.
120. Giulian D, Lachman LB. Interleukin-1 stimulation of astroglial proliferation after brain injury. Science 1985; 228: 497-499.
121. Berkenbosch F. Macrophages and astroglial interactions in repair to brain injury. Ann NY Acad Sci USA 1992; 650: 186-190.
122. Giulian D, Li J, Li X, George J, Rutecki PA. The impact of microglia-derived cytokines upon gliosis in the CNS. Dev Neurosci 1994; 16: 128-136.
123. Frei K, Bodmer S, Schwerdel C, Fontana A. Astrocyte-derived interleukin 3 as a growth factor for microglial cells and peritoneal macrophages. J Immunol 1986; 137: 3521-3527.
124. Thery C, Stanley ER, Mallat M. Interleukin 1 and tumor necrosis factor-alpha stimulate the production of colony-stimulating factor 1 by murine astrocytes. J Neurochem 1992; 59: 1183-1186.
125. Liu W, Brosnan CF, Dickson DW, Lee SC. Macrophage colony-stimulating factor mediates astrocyte-induced microglial ramification in human fetal central nervous system culture. Am J Pathol 1994; 145: 48-53.
126. Giulian D, Ingeman JE. Colony-stimulating factors as promotors of ameboid microglia. J Neurosci 1988; 8: 4707-4717.
127. Sawada M, Suzumura A, Yamamoto H, Marunouchi T. Activation and proliferation of the isolated microglia by colony stimulating factor-1 and possible involvement of protein kinase C. Brain Res 1990; 509: 119-124.
128. Suzumura A, Marunouchi T, Yamamoto H. Morphological transformation of microglia in vitro. Brain Res 1991; 545: 301-306.
129. Tanaka J, Maeda N. Microglial ramification requires nondiffusible factors derived from astrocytes. Exp Neurol 1996; 137: 367-375.
130. Sievers J, Parwaresch R, Wottge H. Blood monocytes and spleen macrophages differentiate into microglia-like cells on monolayers of astrocytes: morphology. GLIA 1994; 12: 245-258.
131. Schmidtmayer J, Jacobsen C, Miksch G, Sievers J. Blood monocytes and spleen macrophages differentiate into microglia-like cells on monolayers of astrocytes: membrane currents. GLIA 1994; 12: 259-267.
132. Griffin WST, Stanley LC, Ling C, White L, MacLeod V, Perrot IJ, et al. Brain interleukin-1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease. Proc Natl Acad Sci USA 1989; 86: 7611-7615.
133. Hertz L. Neuronal-astrocytic interactions in brain development, brain function and brain disease. Adv Exp Med Biol 1991; 296: 143-159.
134. Brenneman DE, Schultzberg M, Bartfai T, Gozes I. Cytokine regulation of neuronal survival. J Neurochem 1992; 58: 454-460.
135. Vaca K, Wendt E. Divergent effects of astroglial and microglial secretions on neuron growth and survival. Exp Neurol 1992; 118: 62-72.
136. Langeveld CH, Jongenelen CAM, Schepens E, Stoof JC, Bast A, Drukarch B. Cultured rat striatal and cortical astrocytes protect mesencephalic dopaminergic neurons against hydrogen peroxide toxicity independent of their effect on neuronal development. Neurosci Lett 1995; 192: 13-16.
137. Garcia-Abreu J, Neto M, Carvalho SL, Cavalcante LA. Regionally specific properties of midbrain glia: I. Interactions with midbrain neurons. J Neurosci Res 1995; 40: 471-477.
138. Dong JF, Detta A, Bakker MHM, Hitchcock ER. Direct interaction with target-derived glia enhances survival but not differentiation of human fetal mesencephalic dopaminergic neurons. Neuroscience 1993; 56: 53-60.
139. Bowenkamp KE, Hoffman AF, Gerhardt GA, Henry MA, Biddle PT, Hoffner BJ, et al. Glial cell line-derived neurotrophic factor supports survival of injured midbrain dopaminergic neurons. J Comp Neurol 1995; 355: 479-489.
140. Banker GA. Trophic interactions between astroglial cells and hippocampal neurons in culture. Science 1980; 209: 809-810.
141. Noble M, Fok-Seang J, Cohen J. Glia are a unique substrate for the in vitro growth of central nervous system neurons. J Neurosci 1984; 4: 1892-1903.
142. Schmalenbach C, Muller HW. Astroglia-neuron interactions that promote long-term neuronal survival. J Chem Neuroanat 1993; 6: 229-237.
143. Hatten ME, Mason CA. Neuron-astroglial interactions in vitro and in vivo. Trends Neuroscience 1986; 168-174.
144. Miller C, Tsatas O, David S. Dibutyryl cAMP, interleukin-1β, and macrophage conditioned medium enhance the ability of astrocytes to promote neurite growth. J Neurosci Res 1994; 38: 56-63.
145. Dugan L, Bruno VMG, Amagasu SM, Giffard RG. Glia modulate the response of murine cortical neurons to excitotoxicity: glia exacerbate AMPA neurotoxicity. J Neurosci 1995; 15: 4545-4555.
146. Swanson RA, Choi DW. Glial glycogen stores affect neuronal survival during glucose deprivation in vitro. J Cereb Bood Flow Metab 1993; 13: 162-169.
147. Kimelberg HK, Norenberg MD. Astrocytes. Sci Am 1989; April: 44-52.
148. Johnston PV, Roots BI. Neuron-glial relationships. In: Handbook of Clinical Neurology. Amsterdam: North-Holland, 1976; 401-421.
149. Nagata K, Takei N, Nakajima K, Saito H, Kohsaka S. Microglial conditioned medium promotes survival and development of cultured mesencephalic neurons from embryonic rat brain. J Neurosci Res 1993; 34: 357-363.
150. Mallat M, Houlgatte R, Brachet P, Prochiantz A. Lipopolysaccharide-stimulated rat brain macrophages release NGF in vitro. Dev Biol 1989; 133: 309-311.
151. Chamak B, Dobbertin A, Mallat M. Immunohistochemical detection of thrombospondin in microglia in the developing rat brain. Neuroscience 1995; 69: 177-187.
152. Chamak B, Morandi V, Mallat M. Brain macrophages stimulate neurite growth and regeneration by secreting thrombospondin. J Neurosci Res 1994; 38: 221-233.
153. Shimojo M, Nakajima K, Takei N, Hamanoue M, Kohsaka S. Production of basic fibroblast growth factor in cultured rat brain microglia. Neurosci Lett 1991; 123: 229-231.
154. Araujo DM, Cotman CW. Basic FGF in astroglial, microglial, and neuronal cultures: characterization of binding sites and modulation of release by lymphokines and trophic factors. J Neurosci 1992; 12: 1668-1678.
155. Yoshida K, Kakihana M, Chen LS, Ong M, Baird A, Gage FH. Cytokine regulation of nerve growth factor-mediated cholinergic neurotrophic activity synthesized by astrocytes and fibroblasts. J Neurochem 1992; 59: 919-931.
156. Yoshida K, Gage FH. Cooperative regulation of nerve growth factor synthesis and secretion of fibroblasts and astrocytes by fibroblast growth factor and other cytokines. Brain Res 1992; 569: 14-25.
157. Merill JE. Tumor necrosis factor alpha, interleukin 1 and related cytokines in brain development: normal and pathological. Dev Neurosci 1992; 14: 1-10.
158. Strijbos PJLM, Rothwell NJ. Interleukin-1β attenuates excitatory amino acid-induced neurodegeneration in vitro: involvement of nerve growth factor. J Neurosci 1995; 15: 3468-3474.
159. Hama T, Kushima Y, Miyamoto M, Kubota M. Takei N. Hatanaka H. Interleukin-6 improves the survival of mesencephalic catecholaminergic and septal cholinergic neurons from postnatal two-week-old rats in cultures. Neuroscience 1991; 40: 445-452.
160. Akaneva Y, Takahishi M, Hatanaka H. Interleukin-1β enhances survival and interleukin-6 protects against MPP+ neurotoxicity in cultures of fetal rat dopaminergic neurons. Exp Neurol 1995; 136: 44-52.
161. Giulian D, Corpuz M. Microglial secretion products and their impact on the nervous system. Adv Neurol 1993; 59: 315-320.
162. Giulian D, Vaca K, Noonan CA. Secretion of neurotoxins by mononuclear phagocytes infected with HIV-1. Science 1990; 250: 1593-1596.
163. Aswell K. The distribution of microglia and cell death in the fetal rat forcbrain. Dev Brain Res 1991; 58: 1-12.
164. Hume DA, Perry VH, Gordon S. Immunohistochemical localization of a macrophage-specific antigen in developing mouse retina: phagocytosis of dying neurons and differentiation of microglial cells to form a regular array in the plexiform layers. J Cell Biol 1983; 97: 253-257.
165. Ferrer I, Bernet E, Soriano E, Del Rio T, Fonseca M. Naturally occurring cell death in the cerebral cortex of the rat and removal of dead cells by transitory phagocytes. Neuroscience 1990; 39: 452-458.
166. Innocenti GM, Clarke S, Koppel H. Transitory macrophages in the white matter of the developing visual cortex. II. Development and relations with axonal pathways. Dev Brain Res 1983; 11: 55-66.
167. Colton CA, Gilbert DL. Microglia, an in vivo source of reactive oxygen species in the brain. Adv Neurol 1993; 59: 321-326.
168. Van Muiswinkel FL, Veerhuis R, Eikelenboom P. Amyloid β protein primes cultured rat microglial cells for an enhanced phorhol 12-myristate 13-acetate-induced respiratory burst activity. J Neurochem 1996; 66: 2468-2476.
169. Banati RB, Hoppe K, Gottmann K, Kreutzberg GW. Cytotoxicity of microglia. GLIA 1993; 30: 111-118.
170. Banati RB, Rothe G, Valet G, Kreutzberg GW. Detection of lysosomal cysteine proteinases in microglia: flow cytometric measurement and histochemical localization of cathepsin B and L. GLIA 1993; 7: 183-191.
171. Colton AC, Gilbert DL. Production of superoxide by a CNS macrophage. the microglia. FEBS Lett 1987; 223: 284-288.
172. Thery C, Chamak B, Mallat M. Free radical killing of neurons. Eur J Neurosci 1991; 3: 1155-1164.
173. Dickson DW, Lee SC, Mattiace LA, Yen S, Brosnan CF. Microglia and cytokines in neurological disease, with special reference to AIDS and Alzheimer's disease. GLIA 1993; 7: 75-83.
174. Chao CC, Hu S. Tumor necrosis factor-alpha potentiates glutamate neurotoxicity in human fetal brain cell cultures. Dev Neurosci 1994: 16: 172-179.
175. Piani D, Frei K, Quang Do K, Cuenod M, Fontana A. Murine brain macrophages induce NMDA receptor mediated neurotoxicity in vitro by secreting glutamate. Neurosci Lett 1991; 133: 159-162.
176. Thery C, Chamak B, Mallat M. Cytotoxic effect of brain macrophages on developing neurons. Eur J Neurosci 1991; 3: 1155-1164.
177. Streit WJ. Microglial-neuronal interactions. J Chem Neuroanat 1993; 6: 261-266.
178. Vincent VAM, Lowik CWGM, Verheijen JH, Tilders FJH, Van Dam A-M. Role of astrocyte-derived tissue-type plasminogen activator in the regulation of endotoxin stimulated nitric oxide production by microglial cells. GLIA 1998; 22: 130-137.
179. Gower DB. Modifiers of steroid-hormone metabolism: a review of their chemistry biochemistry and clinical applications. J Steroid Biochem 1974; 5: 501-523.
180. Giulian D. Reactive glia as rivals in regulating neuronal survival. GLIA 1993; 7: 102-110.
181. Furchgott RF, Zawadzki JV. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 1980; 288: 373-376.
182. Marletta MA. Nitric oxide synthase structure and mechanism. J Biol Chem 1993; 268: 12231-12234.
183. Janssens SP, Shimouchi A, Quertermous T, Bloch DB, Block KD. Cloning an expression of a cDNA encoding human endothelium-derived relaxing factor/nitric oxide synthase. J Biol Chem 1992; 267: 14519-14522.
184. Forstermann U, Schmidt HHHW, Pollock JS, sheng H, Mitchell JA, Warner TD, et al. Isoforms of nitric oxide synthase. Characterization and purification from different cell types. Biochem Pharmacol 1991; 42: 1849-1857.
185. Murphy S, Simmons ML, Agullo L, Garcia A, Feinstein DL, Galea E, et al. Synthesis of nitric oxide in CNS glial cells. Trends Neurosci 1993; 16: 323-328.
186. Bredt DS, Snyder SH. Nitric oxide, a novel neuronal messenger. Neuron 1992; 8: 3-11.
187. Snyder SH. Nitric oxide: first in a new class of neurotransmitters? Science 1992; 257: 494-496.
188. Ignarro LJ, Gold ME, Buga GM. Basic polyamino acids rich in arginine. lysine, or ornithine cause both enhancement of and refractoriness to formation of endothelium-derived nitric oxide in pulmonary artery and vein. Circ Res 1989; 64: 315-329.
189. Tzeng TB, Fung HL. Pharmacodynamic modeling of the in vitro vasodilating effects of organic mononitrates. J Pharmacokinet Biopharm 1992; 20: 227-251.
190. Holscher C, Rose PR. An inhibitor of nitric oxide synthesis prevents memory formation in the chick. Neuronsci Lett 1992; 145: 165-167.
191. Hawkins RD. NO honey. I don't remember. Neuron 1996; 16: 465-467.
192. Schuman EM, Madison DV. A requirement for the intercellular messenger nitric oxide in long-term potentiation. Science 1991; 254: 1503-1506.
193. Ohno M, Yamamoto T, Watanabe S. Deficits in working memory following inhibition of hippocampal nitric oxide synthesis in the rat. Brain Res 1993; 632: 36-40.
194. Bredt DS, Glatt CE, Hwang PM, Fotuhi M, Dawson TM, Snyder SH. Nitric oxide synthase protein and mRNA are discretely localized in neuronal populations of the mammalian CNS together with NADPM cliaphorase. Neuron 1991; 7: 615-624.
195. Benyo Z, Szabo C, Stuiver BT, Bohus B, Sandor P. Effect of chronic nitric oxide synthase blockade on local hypothalamic blood flow in rats. Neurosci Lett 1995; 198: 127-130.
196. Lowenstein CJ, Glatt CS, Bredt DS, Snyder SH. Cloned and expressed macrophage nitric oxide synthase contrasts with the brain enzyme. Proc Natl Acad Sci USA 1992; 89: 6711-6715.
197. Green SJ, Nacy CA. Antimicrobial and immunopathologic effects of cytokine-induced nitric oxide synthesis. Curr Opin Infect Dis 1993; 6: 384-396.
198. Nathan C. Nitric oxicle as a secretory product of mammalian cells. FASEB J 1992; 6: 3051-3064.
199. Marletta MA, Yoon PS, Iyengar R, Leaf CD, Wishnik JS. Macrophage oxidation of L-arginine to nitrite and nitrate nitric oxide is an intermediate. Biochemistry 1988; 27: 8706-8711.
200. Koprowski H, Zheng YM, Heber-Katz E. In vivo expression of inducible nitric oxide synthase in experimentally induced neurologic diseases. Proc Natl Acad Sci USA 1993; 90: 3024-3027.
201. Bolanos JP, Heales SJ, Land JM, Clark JB. Effect of peroxynitrite on the mitochondrial respiratory chain: differential susceptibility of neurons and astrocytes in primary culture. J Neurochem 1995; 64: 1965-1972.
202. Boje KM, Arora PK. Microglial-produced nitric oxide and reactive nitrogen oxides mediate neuronal cell death. Brain Res 1992; 587: 250-256.
203. Galea E, Feinstein DL, Reis DJ. Induction of calcium-independent nitric oxide synthase activity in primary rat glial cultures. Proc Natl Acad Sci USA 1992; 89: 10945-10949.
204. Iadecola C, Xu X, Zhang F, El-Fakahany E, Ross ME. Marked induction of calcium-independent nitric oxide synthase activity after focal cerebral ischemia. J Cereb Blood Flow Metab 1995; 15: 52-59.
205. Iadecola C, Zhang F, Xu S. Casey R, Ross ME. Inducible nitric oxide synthase gene expression in brain following cerebral ischemia. J Cereb Bood Flow Metab 1995; 15: 378-384.
206. Choi DW. Glutamate neurotoxicity and diseases of the nervous system. Neuron 1988; 1: 623-634.
207. Meldrum B, Garthwaite J. Excitatory amino acid neurotoxicity and neurodegenerative disease. Trends Pharmacol Sci 1990; 11: 379-387.
208. Garthwaite J. Glutamate, nitric oxide and cell-cell signalling in the nervous system. Trends Neurosci 1991; 14: 60-67.
209. Simonian NA, Coyle JT. Oxidative stress in neurodegeneratiwe diseases. Annu Rev Pharmacol Toxicol 1996; 36: 83-106.
210. Zhang J, Snyder SH. Nitric oxide in the nervous system. Annu Rev Pharmacol Toxicol 1995; 35: 213-233.
211. Dawson TD, Dawson VL, Snyder SH. Molecular mechanisms of nitric oxide actions in the brain. Ann NY Acad Sci USA 1994; 738: 76-85.
212. Huang Z, Huang PL, Panahian N, Dalkara T, Fishman MC, Moskowitz MA. Effects of cerebral ischemia in mice deficient in neuronal nitric oxide synthase. Science 1994; 265: 1883-1885.
213. Dawson VL, Dawson TM. Nitric oxide neurotoxicity. J Chem Neuroanat 1996; 10: 179-190.
214. Butz EA, Hostager BS, Southern PJ. Macrophages in mice acutely infected with lymphocytic choriomeningitis virus are primed for nitric oxide synthesis. Microbiol Pathogen 1994; 16: 283-295.
215. Campbell IL, Samii A, Chiang CS. Expression of inducible nitric oxide synthase. Correlation with neurology and clinical features in mice with lymphocytic choriomeningitis. J Immunol 1994; 153: 3622-3629.
216. Van Dam A-M, Bauer J, Man-A-Hing WKH, Marquette C, Tilders FJH, Berkenbosch F. Appearance of inducible nitric oxide synthase in the rat central nervous system after rabies virus infection and during experimental allergic encephalmyelitis but not after peripheral administration of endotoxin. J Neurosci Res 1995; 40: 251-260.
217. Zheng YM, Schafer MK, Weihe E, Sheng H, Corisdeo S, Fu ZF, et al. Severity of neurological signs and degree of inflammatory lesions in the brains of rats with Borna disease correlate with the induction of nitric oxide synthase. J Virol 1993; 67: 5786-5791.
218. Korytko PJ, Boje KMK. Pharmacological characterization of nitric oxide production in a rat model of meningitis. Neuropharmacology 1996; 35: 231-237.
219. Gazzinelli RT, Eltoum I, Wynn TA, Sher A. Acute cerebral toxoplasmosis is induced by in vivo neutralization of TNF-alpha and correlates with the downregulated expression of inducible nitric oxide synthase and other markers of macrophage activation. J Immunol 1993; 151: 3672-3681.
220. Bo L, Dawson TM, Wesselingh S, Mork S, Choi S, Kong PA, et al. Induction of nitric oxide synthase in demyelinating regions of multiple regions of multiple silcrosis brains. Ann Neurol 1994; 36: 781-786.
221. Merrill JE, Ignarro LJ, Sherman MP, Melinek J, Lane TE. Microglial cell cytotoxicity of oligodendrocytes is mediated through nitric oxide. J Immunol 1993; 151: 2132-2141.
222. Chao CC, Hu S, Molitor TW, Shaskan EG, Peterson PK. Activated microglia mediate neuronal cell injury via a nitric oxide mechanism. J Immunol 1992; 149: 2736-2741.
223. Beckman JS, Beckman TW, Chen J, Marshall PA, Freeman BA. Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide. Proc Natl Acad Sci USA 1990; 87: 1620-1624.
224. Zhang J, Dawson VL, Dawson TM, Snyder SH. Nitric oxide activation op poly (ADP-ribose) synthase in neurotoxicity. Science 1994; 263: 687-689.
225. Bolanos JP, Peuchen S, Heales SJR, Land JM, Cark JB. Nitric oxide-mediated inhibition of the mitochondrial respiratory chain in cultured astrocytes. J Neurochem 1994; 63: 910-916.
226. Reif DW, Simmons RD. Nitric oxide mediates iron release from ferritin. Arch Biochem Biophys 1990; 283: 537-541.
227. Stuehr DJ, Nathan CF. A macrophage product responsible for cytostasis and respiratory inhibition in tumor target cells. J Exp Med 1989; 169: 1543-1555.
228. Lipton SA, Singel DJ, Stamler JS. Nitric oxide in the central nervous system. Prog Br Res 1994; 103: 359-364.
229. Bonfoco E, Kraine D, Ankarcrona M, Nicotera P, Lipton S. Apoptosis and necrosis: two distinct events induced, respectively, by mild and intense insults with NMDA or nitric oxide/superoxide in cortical cell cultures. Proc Natl Acad Sci USA 1995; 92: 7162-7166.
230. Estevez AG, Radi R, Barbeito L, Shin JT, Thompson JA, Beckman JS. Peroxynitrite-induced cytotoxicity in PC12 cells: evidence for an apoptotic mechanism differentially modulated by neurotrophic factors. J Neurochem 1995; 65: 1543-1550.
231. Mitrovic B, Ignarro LJ, Vinters HV, Akers MA, Schmid I, Uittenbogaart CL, et al. Nitric oxide induces necrotic but not apoptotic cells in oligodendrocytes. Neuroscience 1995; 65: 531-539.
232. Peunova N, Enikolopov G. Amplification of calcium-induced gene transcription In nitric oxide in neuronal cells. Nature 1993; 364: 450-453.
233. Nicotera P, Bonfoco E, Brune B. Mechanisms for nitric oxide-induced cell death: involvement of apoptosis. Adv Neuroimm 1995; 5: 411-420.
234. Dorheim MA, Iracey WR, Pollock JS, Grammas P. Nitric oxide synthase activity is elevated in brain microvessels in Alzheimer's disease. Biochem Biophys Res Commun 1994; 205: 659-665.
235. Vodovotz Y, Lucia MS, Flanders C, Chester L, Xie QS, Smith TW, Weidner J, et al. Inducible nitric oxide synthase in tangle-bearing neurons or patients with Alzheimer's disease. J Exp Med 1996; 184: 1425-1433.
236. Sherman MP, Griscavage JM, Ignarro LJ. Nitric oxide-mediated neuronal injury in multiple sclerosis. Med Hypotheses 1992; 39: 143-146.
237. Cross AH, Keeling RM, Goorha S, San M, Rodi C, Wyatt PS, et al. Inducible nitric oxide synthase gene expression and enzyme activity correlate with disease activity in murine experimental autoimmune encephalomyelitis. J Neuroimmunol 1996; 71: 145-153.
238. Bagasra O, Michaels FH, Mu Zheng Y, Bobroski LE, Spitsin SV, Fang Fu Z, et al. Activation of the inducible form of nitric oxide synthase in the brains of patients with multiple sclerosis. Proc Natl Acad Sci USA 1995; 92: 12041-12045.
239. Brosnan CF, Battistini L, Raine CS, Dickson DW, Casedevall A, Lee SC. Reactive nitrogen intermediates in human neuropathology: an overview. Dev Neurosci 1994; 16: 152-161.
240. De Groot CJA, Ruuls SR, Theeuwes JWM, Dijkstra CD, Van der Valk P. Immunocytochemical characterization of the expression of inducible and constitutive isoforms of nitric oxide synthase in demyelinating multiple sclerosis lesions. J Neuropathol Exp Neurol 1997; 56: 10-20.
241. Zhao W, Tilton RG, Corbett JA, McDaniel ML, Misko TP, Williamson JR, et al. Experimental allergic encephalomyelitis in the rat is inhibited by aminoguanidine, an inhibitor of nitric oxide synthase. J Neuroimmunol 1996; 64: 123-133.
242. Beck J, Rondot P, Catinot L, Falcoff E, Kirchner H, Wietzerbin J. Increased production of interferon gamma and tumor necrosis factor precedes clinical manifestation in multiple sclerosis: do cytokines trigger off exacerbations. Acta Neurol Scand 1988; 78: 318-330.
243. Hofman FM, Hinton DR, Johnson K, Merrill JE. Tumor necrosis factor identified in multiple sclerosis brain. J Exp Med 1989; 170: 607-612.
244. Merrill JE, Strom SR, Ellison GW, Myers LW. In vitro study of mediators of inflammation in multiple sclerosis. J Clin Immunol 1989; 9: 84-96.
245. Panitch HS, Hirsch RL, Schindler J, Johnson KP. Treatment of multiple sclerosis with gamma interferon: exacerbations associated with activation of the immune system. Neurology 1987; 37: 1097-1100.
246. Adamson DC, Wildemann B, Sasaki M, Glass JD, McArthur JC, Christov VI, et al. Immunologic NO synthase: elevation in severe AIDS dementia and induction by HIV-1 gp41. Science 1996; 274: 1917-1920.
247. Nuovo GJ, Lynn Alfieri M. AIDS dementia is associated with massive, activated HIV-1 infection and concomitant expression of several cytokines. Mol Med 1996; 2: 358-366.
248. Lane TE, Buchmeier J, Watry DD, Fox HS. Expression of inflammatory cytokines and inducible nitric oxide synthase in brains of SIV-infected rhesus monkeys: applications to HIV-induced central nervous system disease. Mol Med 1996; 2: 27-37.
249. Vazeux R, Brousse N, Jarry A, Henin D, Marche C, Vedrenne C, et al. AIDS subacute encephalitis; identification of HIV-infected cells. Am J Pathol 1987; 126: 403-410.
250. Lee SC, Dickson DW, Liu W, Brosnan CF. Induction of nitric oxide synthase activity in human astrocytes by interleukin-1β and interferon-gamma. J Neuroimmunol 1993; 46: 19-24.
251. Maddon PJ, Dalgleish AG, McDougal JS, Clampham PR, Weiss RA, Axel R. The T4 gene encodes the AIDS virus receptor and is expressed in the immune system and the brain. Cell 1986; 47: 333-348.
252. Genis P, Jett M, Bernton EW, Boyle T, Gelbard HA, Dzenko K, et al. Cytokines and arachidonic metabolites produced during human immunodeficiency virus (HIV)-infected macrophage-astroglia interactions: implications for the neuropathogencsis of HIV disease. J Exp Med 1992; 176: 1703-1718.
253. Yeung MC, Pulliam L, Lau AS. The HIV envelope protein gp120 is toxic to human brain-cell cultures through the induction of interleukin-6 and tumor necrosis factor-alpha. AIDS 1995; 9: 137-143.
254. Epstein LG, Gendelman HE. Human immunodeficiency virus type 1 infection of the nervous system: pathogenetic mechanisms. Ann Neurol 1993; 33: 429-436.
255. Wiley CA, Achim CL, Schrier RD, Heyes MP, McCutchan JA, Grant I. Relationship of cerebrospinal fluid immune activation associated factors to HIV encephalitis. AIDS 1992; 6: 1299-1307.
256. Achim CL, Heyes M, Wiley CA. Quantitation of human immunodeficiency virus, immune activation factors, and quinolinic acid in AIDS brains. J Clin Invest 1993; 91: 2769-2775.
257. Pietraforte D, Tritarelli E, Testa U, Minetti M. Gp120 HIV envelope glycoprotein increases the production of nitric oxide in human monocyte-derived macrophages. J Leukoc Biol 1994; 55: 175-182.
258. Mollace V, Colasanti M, Persichini T, Bagetta G, Lauro GM, Nistico G. HIV gp120 glycoprotein stimulates the inducible isoform of NO synthase in human cultured astrocytoma cells. Biochem Biophys Res Comm 1993; 194: 439-445.
259. Chao CC, Hu S, Sheng WS, Bu D, Bukrinsky MI, Peterson PK. Cytokine-stimulated astrocytes damage human neurons via a nitric oxide mechanism. GLIA 1996; 16: 276-284.
260. Dawson VL, Bahmbhatt HP, Mong JA, Dawson TM. Expression of inducible nitric oxide synthase causes delayed neurotoxicity in primary mixed neuronal-glial cortical cultures. Neuropharmacology 1994; 33: 1425-1430.
261. Dawson TM, Zhang J, Dawson VL, et al. Nitric oxide: cellular regulation and neuronal injury. In: Seil F, ed. Progress in Brain Research. Amsterdam: Elsevier Science, 1994; 365-369.
262. Wesselingh SL, Takahashi K, Glass KD, McArthur JC, Griffin JW, Griffin DE. Cellular localization of tumor necrosis factor mRNA in neurological tissue from HIV-infected patients by combined reverse transcriptase/ polymerase chain reaction in situ hybridization and immunohistochemistry. J Immunol 1997; 74: 1-8.
263. Yoshioka M, Bradley WG, Shapshak P, Nagano I, Stewart RV, Xin K, et al. Role of immune activation and cytokine expression in HIV-1-associated neurologic diseases. Adv Neuroimmunol 1995; 5: 335-358.
264. Perrella O, Finelli L, Carrieri PB. The role of cytokines in AIDS-dementia complex. Acta Neurologica 1992; 14: 342-344.
265. Sippy BD, Hofman FM, Wallach D, Hinton DR. Increased expression of tumor necrosis factor-alpha receptors in the brains of patients with AIDS. J AIDS Hum Retrovir 1995; 10: 511-521
266. Bukrinsky MI, Nottet HSLM, Schmidtmayerova H, Dubrovsky L, Flanagan CR, Mullins ME, et al. Regulation of nitric oxide synthase activity in human immunodeficiency virus type 1 (HIV-1)-infected monocytes: implications for HIV-associated neurological disease. J Exp Med 1995; 181: 735-745.
267. Colasanti M, Persichini T, Di Pucchio T, Gremo F, Lauro GM. Human ramified microglial cells produce nitric oxide upon Escherichia coli lipopolysaccharide and tumor necrosis factor alpha stimulation. Neurosci Lett 1995; 200: 144-146.
268. Dighiero P, Reux I, Hauw J, Fillet AM, Courtois Y, Goureau O. Expression of inducible nitric oxide synthase in cytomegalovirus-infected glial cells of retinas from AIDS patients. Neurosci Lett 1994; 166: 31-34.
269. Hunot S, Boissiere F, Faucheux B, Brugg B, Mouatt-Prigent A, Agid Y, et al. Nitric oxide synthase and neuronal vulnerability in Parkinson's disease. Neuroscience 1996; 72: 355-363.
270. Connop BP, Boegman RJ, Beninger RJ, Jhamandas K. Attenuation of malonate-induced degeneration of the nigrostriatal pathway by inhibitors of nitric oxide synthase. Neuropharmacology 1996; 35: 459-465.
271. Ischirpoulos H, Duran D, Horwitz J. Peroxynitrite-mediated inhibition of DOPA synthesis in PC12 cells. J Neurochem 1995; 65: 2366-2372.
272. Paakkari I, Lindsberg P. Nitric oxide in the central nervous system. Ann Mat 1995; 27: 369-377.
273. Endoh M, Maiese K, Wagner JA. Expression of the inducible form of nitric oxide synthase by reactive astrocytes after transient global ischemia. Brain Res 1994; 651: 92-100.
274. Nowicki JP, Duval D, Poignet H, Scatton B. Nitric oxide mediates neuronal death after focal cerebral ischemia in the mouse. Eur J Pharmacol 1991; 204: 339-340.
275. Bertini G, Savio T, Zaccheo D, Schmidt HHHW, Bentivoglio M. NADPH-diaphorase activity in brain macrophages during postnatal development in the rat. Neuroscience 1996; 70: 287-293.
276. Wallace MN, Fredens K. Activated astrocytes of the mouse hippocampus contain high levels of NADPH-diaphorase. NeuroReport 1992; 3: 953-956.
277. Glenn JA, Jordan FL, Thomas WE. Further studies on the identification of microglia in mixed brain cell cultures. Brain Res Bull 1989; 22: 1049-1052.
278. Hassan NF, Campbell DE, Rifat S, Douglas SD. Isolation and characterization of human fetal brain-derived microglia in in vitro culture. Neuroscience 1991; 41: 149-158.
279. Gebicke-Haerter PJ, Bauer J, Schobert A, Northoff H. Lipopolysaccharide-free conditions in primary astrocyte cultures allow growth and isolation of microglial cells J Neurosci 1989; 9: 183-194.
280. Thiele DL, Kurosaka M, Lipsky PE. Phenotype of the accessory cell necessary for mitogen-stimulated T and B cell responses in human peripheral blood: delineation by its sensitivity to the lysosomotropic agent. L-leucine methyl ester. J Immunol 1983; 131: 2282-2290.
281. McCarthy KD, Vellis de H. Preparation of separate astroglial and oligodendroglial cell cultures from rat cerebral tissue. J Cell Biol 1980; 85: 890-902.
282. Schwartz JP, Wilson DJ. Preparation and characterization of type 1 astrocytes cultured from adult rat cortex, cerebellum and striatum. GLIA 1992; 5: 75-80.
283. Frei K, Lins H, Schwerdel C, Fontana A. Antigen presentation in the central nervous system: the inhibitory effect of IL-10 on MHC Class II expression and production of cytokines depends on the inducing signals and the type of cell analyzed. J Immunol 1994; 152: 2720-2728.
284. Giulian D, Baker TJ. Characterization of ameboid microglia isolated from developing mammalian brain. J Neurosci 1986; 6: 2163-2178.
285. Suzumura A, Mezitis SGE, Gonatas NK, Silberberg DH. MHC antigen expression on bulk isolated macrophage-microglia from newborn mouse brain: induction of Ia antigen expression by gamma-interferon. J Neuroimmunol 1987; 15: 263-278.
286. Jordan FL, Thomas WE. Identification of microglia in primary cultures of mixed cerebral cortical cells. Brain Res Bull 1987; 19: 153-159.
287. Sutter A, Gerdes C, Jarling F. Microglial contaminants as the source of IL-1 in astrocyte cultures. Abstract First European Meeting on Glial Cell Function in Health and Disease, Heidelberg 1994, March 24-27, p. 174.
288. Kim YS, Tauber MG. Neurotoxicity of glia activated by gram-positive bacterial products depends on nitric oxide production. Infect Immun 1996; 64: 3148-3153.
289. Demerle-Pallardy C, Lonchampt M, Chabrier P. Nitric oxide synthase induction in glial cells: effect on neuronal survival. Life Sci 1993; 52: 1883-1890.
290. Zielasek J, Tausch M, Toyka KV, Hartung H. Production of nitrite by neonatal rat microglial cells/brain macrophages. Cell Immunol 1992; 141: 111-120.
291. Corradin SB, Mauel J, Donini SD, Quattrocchi E, Ricciardi-Castagnoli P. Inducible nitric oxide synthase activity of cloned murine microglial cells. GLIA 1993; 7: 255-262.
292. Zhang X, Morisson DC. Lipopolysaccharide-induced selective priming effects on tumor necrosis factor α and nitric oxide production in mouse peritoneal macrophages. J Exp Med 1993; 177: 511-516.
293. Simmons ML, Murphy S. Induction of nitric oxide in glial cells. J Neurochem 1992; 59: 897-905.
294. Hewett SJ, Corbett JA, McDaniel ML, Choi DW. Interferon-γ and interleukin-1β induce nitric oxide formation from primary mouse astrocytes. Neurosci Lett 1993; 164: 229-232.
295. Galea E, Reis DJ, Fox ES, Xu H, Feinstein DL. CD14 mediates endotoxin induction of nitric oxide synthase in cultured brain glial cells. J Neuroimmunol 1996; 64: 19-28.
296. Simmons ML, Murphy S. Roles for protein kinases in the induction of nitric oxide synthase in astrocytes. GLIA 1994; 11: 227-234.
297. Lee SH, Liu W, Brosnan CF, Dickson DW. Characterization of primary human fetal dissociated central nervous system with an emphasis on microglia. Lab Invest 1992; 67: 465-476.
298. Goureau O, Lepoivre M, Courtois Y. Lipopolysaccharide and cytokines induce a macrophage-type of nitric oxide synthase in bovine retinal pigmented epithelial cells. Biochem Biophys Res Commun 1992; 186: 854-859.
299. Peterson PK, Hu S, Anderson WR, Chao CC. Nitric oxide production and neurotoxicity mediated by activated microglia from human versus mouse brain. J Infect Dis 1994; 170: 457-460.
300. Ruuls SR, Van der Linden S, Sontrop K. Huitinga I, Dijkstra CD. Aggravation of experimental allergic encephalomyelitis by administration of nitric oxide synthase inhibitors. Clin Exp Immunol 1996; 103: 467-476.
301. Ii M, Sunamoto M, Ohnishi K, Ichimori Y. β-amyloid protein-dependent nitric oxide production from microglial cells and neurotoxicity. Brain Res 1996; 720: 93-100.
302. Goodwin JL, Uemura E, Cunnick JE. Microglial release of nitric oxide by the synergistic action of β-amyloid and IFN-gamma. Brain Res 1995; 692: 207-214.
303. Dawson TM, Dawson VL, Snyder SH. A novel neuronal messenger molecule in brain: the free radical, nitric oxide. Ann Neurol 1992; 32: 297-311.
304. Skaper SD, Facci L, Leon A. Inflammatory mediator stimulation of astrocytes and meningeal fibroblasts induces neuronal degeneration via the nitridergic pathway. J Neurochem 1995; 64: 266-276.
305. Chao CC, Molitor TW, Hu S. Neuroprotective role of IL-4 against activated microglia. J Immunol 1993; 151: 1473-1481.
306. Lipton SA. Requirement for macrophages in neuronal injury induced by HIV envelope protein gp120. NeuroReport 1992; 3: 913-915.
307. Bronstein DM, Perez-Otano I, Sun V, Mullis Sawin SB, Chan J, Wu GC, et al. Glia-dependent neurotoxicity and neuroprotection in mesencephalic cultures. Brain Res 1995; 704: 112-116.
308. Gelbard HA, Nottet HSLM, Swindells S, Jett M, Dzenko KA, Genis P, et al. Platelet-activating factor: a candidate human immunodeficiency virus type 1-induced neurotoxin. J Virol 1991; 68: 4628-4635.
309. Misko TP, Moore WM, Kasten TP, Nichols GA, Corbett JA, Tilton RG, et al. Selective inhibition of the inducible nitric oxide synthase by aminoguanidine. Eur J Pharmacol 1993; 233: 119-125.
310. Cross AH, Misko TP, Lin RF, Hickey WF, Trotter JL, Tilton RG. Aminoguanidine, an inhibitor of inducible nitric oxide synthese, ameliorates experimental allergic encephalomyelitis in SJL mice. J Clin Invest 1994; 93: 2684-2690.
311. Romanic AM, Madri JA. Extracellular matrix-degrading proteinases in the nervous system. Brain Pathol 1994; 4: 145-156.
312. Southan GJ, Szabo C. Selective pharmacological inhibition of distinct nitric oxide synthase isoforms. Biochem Pharmacol 1997; 51: 383-394.
313. Park SK, Lin HL, Murphy S. Nitric oxide limits transcriptional induction of nitric oxide synthase in glial cells. Biochem Biophys Res Commun 1994; 201: 762-768.
314. Assreuy J, Cunha FQ, Liew FY, Moncada S. Feedback inhibition of nitric oxide synthase activity by nitric oxide. Br J Pharmacol 1993; 108: 833-837.
315. Feinstein DL, Galeu E, Reis DJ. Norepinephrine suppresses inducible nitric oxide synthase activity in rat astroglial cultures. J Neurochem 1993; 60: 1945-1948.
316. Minghetti L, Nicolini A, Polazzi E, Creminon C, Maclouf J, Levi G. Inducible nitric oxide synthase expression in activated rat microglial cultures is downregulated by exogenous prostaglandin E2 and by cyclooxygenase inhibitors. GLIA 1997; 19: 152-160.
317. Hu S, Sheng WS, Peterson PK, Chao CC. Differential regulation by cytokines of production of nitric oxide by human astrocytes. GLIA 1995; 15: 491-494.
318. Park SK, Grzybicki E, Lin HL, Murphy S. Modulation of inducible nitric oxide synthase expression in astroglial cells. Neuropharmacology 1994; 33: 1419-1423.
319. Perretti M, Szabo C, Thiermermann C. Effect of interleukin-4 and interleukin-10 on leucocyte migration and nitric oxide production in the mouse. Br J Pharmacol 1995; 116: 2251-2257.
320. Liew FY, Ii Y, Severn A, Millott S, Schmidt J, Salter M, et al. A possible novel pathway of regulation by murine T helper type-2 (Th2) cells of a Th1 cell activity via the modulation of the induction of nitric oxide synthase on macrophages. J Immunol 1991; 21: 2489-2494.
321. Young MRI, Farietta T, Crayton JW. Production of nitric oxide and transforming growth factor-β in developing and adult rat brain. Mech Ageing Dev 1995; 79: 115-126.
322. Finch CE, Laping NJ, Morgan TE, Nichols NR, Pasinetti GM. TGF-beta 1 is an organizer of responses to neurodegeneration. J Cell Biochem 1993; 53: 14-22.
323. Kiefer R, Streit WJ, Toyka KV, Kreutzberg GW, Hartung H. Transforming growth factor-β1: a lesion-associated cytokine of the nervous system. Int J Dev Neurosci 1995; 13: 331-339.
324. Wahl SM, Allen JG, McCartney-Francis N, Morganti-Kossmann MC, Kossmann T, Ellingsworth L, et al. Macrophage- and astrocyte-derived transforming growth factor β as a mediator of central nervous system dysfunction in acquired immune deficiency syndrome. J Exp Med 1991; 173: 981-991.
325. Pasinetti GM, Nichols NR, Tocco G, Morgan T, Laping N, Finch CE. Transforming growth factor β1 and fibronectin messenger RNA in rat brain: responses to injury and cell-type localization. Neuroscience 1993; 54: 893-907.
326. Peress NS, Perillo E, Seidman RJ. Glial transforming growth factor (TGF)-β isotypes in multiple sclerosis: differential glial expression of TGF-β1, 2 and 3 isotypes in multiple sclerosis. J Neuroimmunol 1996; 71: 115-123.
327. Flanders KC, Lippa CF, Smith TW, Pollen DA, Sporn MB. Altered expression of transforming growth factor-β in Alzheimer's disease. Neurology 1995; 45: 1561-1569.
328. Peress NS, Perillo E. Differential expression of TGF-beta 1,2 and 3 isotypes in Alzheimer's disease: a comparative immunohistochemical study with cerebral infarction, aged human and mouse control brains. J Neuropathol Exp Neurol 1995; 54: 802-811.
329. Samuels V, Barrett JM, Bockman S, Pantazis CG, Allen MB Jr. Immunocytochemical study of transforming growth factor expression in benign and malignant gliomas. Am J Pathol 1989; 134: 895-902.
330. Yamada N, Kato M, Yamashita H, Nister M, Miyazono K, Heldin C, et al. Enhanced expression of transforming growth factor-β and its type-I and type-II receptors in human glioblastoma. Int J Cancer 1995; 62: 386-392.
331. Cheifetz S, Hernandez H, Leiho M, ten Dijke P, Iwata KK, Massague J. Distinct transforming growth factor-β (TGFβ) receptor subsets as determinants of cellular responsiveness to three TGF-β isoforms. J Biol Chem 1990; 265: 20533-20538.
332. Chao CC, Hu S, Sheng WS, Peterson PK. Tumor necrosis factor-alpha production by human fetal microglial cells: regulation by other cytokines. Dev Neurosci 1995; 17: 97-105.
333. Merrill JE, Zimmerman RP. Natural and induced cytotoxicity of oligodendrocytes by microglia is inhibitable by TGFβ. GLIA 1991; 4: 327-331.
334. Gilbert RS, Herschman HR. Transforming growth factor beta differentially modulates the inducible nitric oxide synthase gene in distinct cell types. Biochem Biophys Res Commun 1993; 195: 380-384.
335. Ding Z, Nathan CF, Graycar J, Derynck R, Stuehr DJ, Srimal S. Macrophage deactivating factor and transforming growth factors-β1, -β2, -β3 inhibit induction of macrophage nitrogen oxide synthesis by IFN gamma. J Immunol 1990; 145: 940-944.
336. Wahl SM, Hunt Da, Wakefield LM, McCartney-Francis N, Wahl LM, Roberts AB, et al. Transforming growth factor beta (TGF-β) induces monocyte chemotaxis and growth factor production. Proc Natl Acad Sci USA 1987; 84: 5788-5792.
337. Racke MK, Ohib-Jalbut S, Cannella B, Albert PS, Raine CS, McFarlin DE. Prevention and treatment of chronic relapsing experimental allergic encephalomyelitis by transforming growth factor-β1. J Immunol 1991; 146: 3012-3017.
338. Kuruvilla AP, Shah R, Hochwald GM, Liggitt HD, Palladino MA, Thorbecke GJ. Protective effect of transforming growth factor β1 on experimental autoimmune diseases in mice. Proc Natl Acad Sci USA 1991; 88: 2918-2921.
339. Karpus WJ, Swanborg RH. CD4+ suppressor cells inhibit the function of effector cells of experimental autoimmune encephalomyelitis through a mechanism involving transforming growth factor-β. J Immunol 1991; 146: 1163-1168.
340. Johns LD, Sriram S. Experimental allergic encephalomyelitis: neutralizing antibody to TGFβ1 enhances the clinical severity of the disease. J Neuroimmunol 1993; 47: 1-8.
341. Santambrogio L, Hochwald GM, Saxena B, Leu C, Martz JE, Carlino JA, et al. Studies on the mechanisms by which tranforming growth factor-β (TGF-β) protects against allergic encephalomyelitis. J Immunol 1993; 151: 1116-1127.
342. Rimaniol A, Lekieffre S, Serrano A, Masson A, Benavides J, Zavala F. Biphasic transforming growth factor-β production flanking the proinflammatory cytokine response in cerebral response in cerebral trauma. NeuroReport 1995; 7: 133-136.
343. Issazadeh S, Mustafa M, Ljungdahl A, Hojeberg B, Dagerlind A, Elde R, et al. Interferon gamma, interleukin 4 and transforming growth factor β in experimental autoimmune encephalomyelitis in Lewis rats: dynamics of cellular mRNA expression in the central nervous system and lymphoid cells. J Neurosci Res 1995; 40: 579-590.
344. McNeill H, Williams C, Guan J, Dragunow M, Lawlor P, Sirimanne E, et al. Neuronal rescue with transforming growth factor-beta 1 after hypoxic-ischaemic brain injury. NeuroReport 1994; 5: 901-904.
345. Lindholm D, Castren E, Kiefer R, Zafra F, Thoenen H. Transforming growth factor-β1 in the rat brain: increase after injury and inhibition of astrocyte proliferation. J Cell Biol 1992; 117: 395-400.
346. Saad B, Constam DB, Ortmann R, Moos M, Fontana A, Schachner M. Astrocyte-derived TGF-β2 and NGF differentially regulate neuronal recognition molecule expression by cultured astrocytes. J Cell Biol 1991; 115: 473-484.
347. Behzadian MA, Wang X, Jiang B, Caldwell RB. Angiostatic role of astrocytes: suppression of vascular endothelial cell growth by TGF-β and other inhibitory factor(s). GLIA 1995; 15: 480-490.
348. Chao CC, Hu S, Sheng WS, Tsang M, Peterson PK. Tumor necrosis factor-alpha mediated the release of bioactive transforming growth factor-beta in murine microglial cell cultures. Clin Immunol Immunopathol 1995; 77: 358-365.
349. da Cunha A, Jefferson JA, Jackson RW, Vitkovic L. Glial cell-specific mechanism of TGF-β1 induction by IL-1 in cerebral cortex. J Neuroimmunol 1993; 42: 71-86.
350. McCartney-Francis N, Mizel D, Wong H, Wahl LM, Wahl SM. TGF-β regulates production of growth factors and TGF-β by human peripheral blood monocytes. Growth Factors 1990; 4: 27-35.
351. Yee JA, Yan L, Dominguez JC, Allan EH, Martin TJ. Plasminogen-dependent activation of latent transforming growth factor beta (TGFβ) by growing cultures of osteoblast-like cells. J Cell Physiol 1993; 157: 528-534.
352. Miyazono K, Yuki K, Takaku F, Wernstedt C, Kanzaki T, Olofsson A, et al. Latent forms of TGF-β: structure and biology. Ann NY Acad Sci 1990; 593: 51-58.
353. Lyons RM, Gentry LE, Purchio AF, Moses HL. Mechanism of activation of latent recombinant transforming growth factor β1 by plasmin. J Cell Biol 1990; 110: 1361-1367.
354. Sprengers ED, Kluft C. Plasminogen activator inhibitors. Blood 1987; 69: 381-387.
355. Oates JA, Wood AJJ. Tissue plasminogen activator. New Engl J Med 1988; 319: 925-931.
356. Wun T. Reich E. An inhibitor of plasminogen activation from human placenta. J Biol Chem 1987; 262: 3646-3653.
357. Verheijen JH, Chang GTG, Kluft C. Evidence for the occurrence of a fast-acting inhibitor for tissue-type plasminogen activator in human plasma. Thromb Haemostas 1984; 51: 392-395.
358. Vassalli JD, Sappino A, Belin D. The plasminogen activator/plasmin system. J Clin Invest 1991; 88: 1067-1072.
359. Nakajima K, Takemoto N, Kohsaka S. Retinoic acid enhances the secretion of plasminogen from cultured rat microglia. FEBS Lett 1992; 314: 167-170.
360. Nakajima K, Tsuzaki N, Naguta K, Takemoto N, Kohsaka S. Production and secretion of plasminogen in cultured rat brain microglia. FEBS Lett 1992; 308: 179-182.
361. Nakajima K, Nagata K, Hamanoue M, Takemoto N, Kohsaka S. Microglia-derived elastase produces a low-molecular-weight plasminogen that enhances neurite outgrowth in rat neocortical explant cultures. J Neurochem 1993; 61: 2155-2163.
362. Faber-Elman A, Miskin R, Schwartz M. Components of the plasminogen activator system in astrocytes are modulated by tumor necrosis factor-alpha and interleukin-1β through similar signal transduction pathways. J Neurochem 1995; 65: 1524-1535.
363. Kalderon N, Ahonen K, Fedoroff S. Developmental transition in plasticity properties of differentiating astrocytes: age-related biochemical profile of plasminogen activators in astroglial cultures. GLIA 1990; 3: 413-425.
364. Toshniwal PK, Firestone SL, Barlow GH, Tiku ML. Characterization of astrocyte plasminogen activator. J Neurol Sci 1987; 80: 277-287.
365. Monard D. Cell-derived proteases and protease inhibitors as regulators of neurite outgrowth. Trends Neurosci 1988; 11: 541-544.
366. Seeds NW, Williams GL, Bickford PC. Tissue plasminogen activator induction in Purkinje neurons after cerebellar motor learning. Science 1995; 270: 1992-1994.
367. Tsirka SE, Rogove AD, Strickland S. Neuronal cell death and tPA. Nature 1996; 384: 123-124.
368. Akenami FOT, Koskiniemi M, Farkkila M, Vaheri A. Cerebrospinal fluid plasminogen activator inhibitor-1 in patients with neurological disease. J Clin Pathol 1997; 50: 157-160.
369. Akenami FOT, Siren V, Koskiniemi M, Siimes MA, Vaheri A. Cerebrospinal fluid activity of tissue plasminogen activator in patients with neurological diseases. J Clin Pathol 1996; 49: 577-580.
370. Cuzner ML, Gveric D, Strand C, Loughlin AJ, Paemen L, Opdenakker G, et al. The expression of tissue-type plasminogen activator, matrix metalloproteases and endogenous inhibitors in the central nervous system in multiple sclerosis: comparison of stages in lesion evolution. J Neuropathol Exp Neurol 1996; 55: 1194-1204.
371. Banati RB, Graeber MB. Surveillance, intervention and cytotoxicity: is there a protective role of microglia? Dev Neurosci 1994; 16: 114-127.
372. Berdeaux A. Nitric oxide: an ubiquitous messenger. Fundam Clin Pharmacol 1993; 7: 401-411.